The Establishment of a Novel In Vitro System for Culturing Cytauxzoon felis

Cytauxzoonosis, a highly fatal tick-borne disease in domestic cats caused by , poses diagnostic and therapeutic challenges due to the inability to culture the parasite in vitro. This study aimed to artificially replicate infection and characterize in vitro replication kinetics. Concanavalin A-activa...

Full description

Saved in:
Bibliographic Details
Published inPathogens (Basel) Vol. 13; no. 7; p. 565
Main Authors Weerarathne, Pabasara, Reichard, Mason, Miller, Craig, Scimeca, Ruth C
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 04.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cytauxzoonosis, a highly fatal tick-borne disease in domestic cats caused by , poses diagnostic and therapeutic challenges due to the inability to culture the parasite in vitro. This study aimed to artificially replicate infection and characterize in vitro replication kinetics. Concanavalin A-activated feline embryonal macrophages (Fcwf-4) were plated at 3-5 × 10 cells/mL and incubated with -positive blood samples from either a (1) chronically infected bobcat ( ), (2) chronically infected domestic cat, or (3) acutely infected domestic cat with clinical signs of cytauxzoonosis. Temporal changes in parasite load were quantified by droplet digital PCR (ddPCR), and the inhibition of infection/replication was assessed using atovaquone, imidocarb dipropionate (ID), artemisinin, ponazuril, and neutralizing antibodies. Tick cell lines AAE2 and ISE6 were also tested for infection. In vitro inoculation with chronic infection led to transient replication, while acute infection resulted in sustained replication beyond 10 days post-inoculation. Atovaquone, ID, and artemisinin inhibited replication, and neutralizing antibodies prevented infection. The inoculation of tick cells in vitro indicated infection; however, parasite replication was not observed. The results of this study established an in vitro model for studying infection dynamics, assessing therapy efficacy, and testing vaccination strategies in cytauxzoonosis-infected cats.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2076-0817
2076-0817
DOI:10.3390/pathogens13070565